Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study

Vallerie V McLaughlin, Derek Solum, Daniel Lachant, Ali Ataya, Joan A Barberà, Gisela Bohns Meyer, Sung-A Chang, Richard Channick, Colin Church, John Feenstra, Sean Gaine, George Giannakoulas, Carlos Jerjes-Sanchez, Dinesh Khanna, Nick H Kim, Ronald Oudiz, Ioana R Preston, Namita Sood, Fernando Torres, Jean-Luc Vachiery, Tomás Pulido, Dana Cella, Chunqin Deng, Miluska Escudero, Victoria Lacasse, Leigh Peterson, Raymond Benza, Marc Humbert

Open source

DOI
10.1016/s0140-6736(26)01011-1
Published
2026-08
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01011-1,
  title = {Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study},
  author = {Vallerie V McLaughlin and Derek Solum and Daniel Lachant and Ali Ataya and Joan A Barberà and Gisela Bohns Meyer and Sung-A Chang and Richard Channick and Colin Church and John Feenstra and Sean Gaine and George Giannakoulas and Carlos Jerjes-Sanchez and Dinesh Khanna and Nick H Kim and Ronald Oudiz and Ioana R Preston and Namita Sood and Fernando Torres and Jean-Luc Vachiery and Tomás Pulido and Dana Cella and Chunqin Deng and Miluska Escudero and Victoria Lacasse and Leigh Peterson and Raymond Benza and Marc Humbert},
  year = {2026},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(26)01011-1},
  url = {https://doi.org/10.1016/s0140-6736(26)01011-1}
}

RIS

TY  - JOUR
TI  - Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
AU  - Vallerie V McLaughlin
AU  - Derek Solum
AU  - Daniel Lachant
AU  - Ali Ataya
AU  - Joan A Barberà
AU  - Gisela Bohns Meyer
AU  - Sung-A Chang
AU  - Richard Channick
AU  - Colin Church
AU  - John Feenstra
AU  - Sean Gaine
AU  - George Giannakoulas
AU  - Carlos Jerjes-Sanchez
AU  - Dinesh Khanna
AU  - Nick H Kim
AU  - Ronald Oudiz
AU  - Ioana R Preston
AU  - Namita Sood
AU  - Fernando Torres
AU  - Jean-Luc Vachiery
AU  - Tomás Pulido
AU  - Dana Cella
AU  - Chunqin Deng
AU  - Miluska Escudero
AU  - Victoria Lacasse
AU  - Leigh Peterson
AU  - Raymond Benza
AU  - Marc Humbert
PY  - 2026
JO  - The Lancet
DO  - 10.1016/s0140-6736(26)01011-1
UR  - https://doi.org/10.1016/s0140-6736(26)01011-1
ER  - 

APA

McLaughlin, V. V., Solum, D., Lachant, D., Ataya, A., Barberà, J. A., Meyer, G. B., Chang, S., Channick, R., Church, C., Feenstra, J., Gaine, S., Giannakoulas, G., Jerjes-Sanchez, C., Khanna, D., Kim, N. H., Oudiz, R., Preston, I. R., Sood, N., Torres, F., Vachiery, J., Pulido, T., Cella, D., Deng, C., Escudero, M., Lacasse, V., Peterson, L., Benza, R., & Humbert, M. (2026). Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study. The Lancet. https://doi.org/10.1016/s0140-6736(26)01011-1

Source records